Clinical trials conducted by COG follow rigorous protocols designed to ensure patient safety and the integrity of the research. These trials are typically divided into phases, each with specific objectives such as assessing the safety of a new drug (Phase I), determining its efficacy (Phase II), or comparing it to the standard treatment (Phase III). Participation in these trials often provides patients with access to new therapies that are not yet widely available.
